Member Info for Ramptastico

The current bid/ask spread is 21% which is insane...

I see 2.10 now being paid again. Looks like MMs are out of stock and we're on our way back up :)

They're in technical testing phase with 3 top 10 companies. They've said expecting announcement before year end for all of them. I think pretty likely we see at least one slip, but not all 3!

Should be gangbusters before the end of year. Expecting at least a double of the share price as a Christmas present!

A reminder also that Tempus Quarterly results are after the US market closing bell tonight, and RENX may well get a mention.

I am patiently waiting for a bid to come along here. Clearly the recent IIs happy to chuck multiple millions of £ at RENX, the bondholders who have converted to equity, as well as the chunky buyers we are seeing all expect a significant uplift in the value of the company.

Follow the money! Happy holder here, in fact added a smidge yesterday 😊

Good luck everyone! Sunny future ahead for us!

They’re not selling it’s to do with the custody of assets between accounts as UBS hold in nominee for their client. There is no buying or selling going on. Their position remains the same throughout all these RNSs

I've just seen that Tempus' Q4 Trading Update is the 4th November, so RENX may get a mention in that

So in about a month we should really be getting a Q1 2026 trading update....

Hopefully we get FY results very soon - the company did say would be released in October so should be any day. Last year in this period we had:

21st Nov 2024 7:00 am RNS Audited Full Year Fiscal 2024 Results

20th Nov 2024 7:00 am RNS Financial Results for Q1 of Fiscal Year 2025

31st Oct 2024 2:10 pm RNS Result of General Meeting

11th Oct 2024 4:55 pm RNS Posting of Circular & Notice of GM

1st Oct 2024 12:02 pm RNS Result of Placing and Subscription

1st Oct 2024 7:00 am RNS Audited US GAAP financial results

Lol check the previous RNSs from UBS. These notifications are just a result of their custody services for clients. They're not down to 0 they're just moving between accounts or something. I had this confirmed by Walbrook PR, RENX investor relations. Expect to see an RNS in next day or so saying UBS have gone from 0% to 5% which is what happened the last time there was an 8% to 0% RNS (a few weeks ago)

Computer expert is toptradersadvfn from twitter btw haha. He always does this so can freely ignore.

This TR1 is just the notification of the convertible loan holders. They haven’t bought more just converted their loan to shares.

Our US listing is holding up better than the UK one haha

It's a bug with their reporting tool I am 99.99% sure.

I have emailed investor relations to ask them to address the issue and will update on any response.

Institutions have only increased their holdings lol, what are you on about? 😂

Down on very light volume, hopefully will shake out some weak hands!

Guys it’s a bug with their automatic reporting tool as I highlighted earlier 😂 They couldn’t have sold 7% of the co. because there hasn’t been enough traded volume to do so! Best to get in context with RENX investor relations directly and in turn they will get in touch with UBS and rectify. UBS will have no idea its even happening.

1) Placing flippers need to clear. Plenty of people like TopTradersADVFN from X will just be ramping the stock in order to sell their placing shares for 10-20% return. Easy money trade that you can do many times a year.

2) Re there already being CKD tests with a CE Mark - RENX have the ONLY one that provides info on severity of disease which is critical in treatment outcomes for patients. Of course there are existing tests for it, or else how would any doctors be able to diagnose lol.

3) It's not a medical device, it's a blood test analysed in a lab. Simpler and faster to approve than something that requires a full audit of an electronic device. Why are you doubting the company's guidance on this unnecessarily?

This RNS was great news as further regulatory hurdles in the process to being cleared (the biggest barrier to entry for competitors imo). FDA + CE Mark paves the way for the rest of the world to fall in.

Haha the TR1 threshold rule isn’t even 5% it’s 3% 😂

Easy answer here - they’re not :)

I think good chance this is just a data error from an automated reporting tool as it’s been happening for months. UBS’s system will auto report the position change so there is a bug in it where it says previous position. Previous position is the 5%+ they had last RNS moving to 7%+ today. They’re not selling from 5 to 0 then buying back to 7 lol guys come on haha